Safety and Immunogenicity of a Hexavalent Vaccine (DTwP-HepB-Hib-IPV) in Toddlers and Infants.

Trial Profile

Safety and Immunogenicity of a Hexavalent Vaccine (DTwP-HepB-Hib-IPV) in Toddlers and Infants.

Recruiting
Phase of Trial: Phase I/II

Latest Information Update: 15 Dec 2016

At a glance

  • Drugs Hib-DTP-hepatitis B-poliovirus vaccine (Primary) ; Hib-DTP-hepatitis B vaccine; Poliovirus vaccine inactivated
  • Indications Acquired immunodeficiency syndrome; Diphtheria; Hepatitis B; Influenza virus infections; Pertussis; Poliomyelitis; Tetanus
  • Focus Adverse reactions
  • Sponsors Shantha Biotechnics
  • Most Recent Events

    • 05 Dec 2016 Status changed from not yet recruiting to recruiting.
    • 17 Nov 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top